These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 26731563)

  • 1. Ovarian cancer: epidemiology and risk factors.
    La Vecchia C
    Eur J Cancer Prev; 2017 Jan; 26(1):55-62. PubMed ID: 26731563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
    Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
    Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and reproductive factors and the risk of ovarian cancer.
    Koushik A; Grundy A; Abrahamowicz M; Arseneau J; Gilbert L; Gotlieb WH; Lacaille J; Mes-Masson AM; Parent MÉ; Provencher DM; Richardson L; Siemiatycki J
    Cancer Causes Control; 2017 May; 28(5):393-403. PubMed ID: 28102526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical relevance of the epidemiology of ovarian cancer.
    La Vecchia C; Franceschi S; Liberati A; Gallus G; Tognoni G
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):175-82. PubMed ID: 6368240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive and hormonal factors and ovarian cancer.
    Chiaffarino F; Pelucchi C; Parazzini F; Negri E; Franceschi S; Talamini R; Conti E; Montella M; La Vecchia C
    Ann Oncol; 2001 Mar; 12(3):337-41. PubMed ID: 11332145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer.
    Tavani A; Ricci E; La Vecchia C; Surace M; Benzi G; Parazzini F; Franceschi S
    Int J Epidemiol; 2000 Oct; 29(5):799-802. PubMed ID: 11034959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual factors and the risk of epithelial ovarian cancer.
    Parazzini F; La Vecchia C; Negri E; Gentile A
    J Clin Epidemiol; 1989; 42(5):443-8. PubMed ID: 2732772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for endometrioid, mucinous and serous benign ovarian cysts.
    Parazzini F; La Vecchia C; Franceschi S; Negri E; Cecchetti G
    Int J Epidemiol; 1989 Mar; 18(1):108-12. PubMed ID: 2722352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population attributable risk for ovarian cancer.
    Parazzini F; Chatenoud L; Chiantera V; Benzi G; Surace M; La Vecchia C
    Eur J Cancer; 2000 Mar; 36(4):520-4. PubMed ID: 10717530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic types of epithelial ovarian cancer: have they different risk factors?
    Kurian AW; Balise RR; McGuire V; Whittemore AS
    Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
    Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of ovarian cancer: a summary review.
    La Vecchia C
    Eur J Cancer Prev; 2001 Apr; 10(2):125-9. PubMed ID: 11330452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the association of oral contraceptives and ovarian cancer.
    Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
    N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.